Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Gossamer Bio (GOSS) R&D In Process (2022 - 2023)

Gossamer Bio (GOSS) has 2 years of R&D In Process data on record, last reported at $15000.0 in Q2 2023.

  • For Q2 2023, R&D In Process changed 0.0% year-over-year to $15000.0; the TTM value through Jun 2023 reached $60000.0, changed N/A, while the annual FY2022 figure was $65000.0, 13.33% down from the prior year.
  • R&D In Process reached $15000.0 in Q2 2023 per GOSS's latest filing, roughly flat from $15000.0 in the prior quarter.
  • Across five years, R&D In Process topped out at $20000.0 in Q1 2022 and bottomed at $15000.0 in Q2 2022.